Skip to main content
Search
Home    /    Insights & Resources

Insights & Resources

Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.

The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.
Explore year-end considerations including the critical aspects of 45Z credits, ITC for biogas and strategies for clean fuel production credits.
The National Association of Manufacturers (NAM) conducted its Q3 Outlook Survey. Read more for a discussion and analysis of the results.
The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.
The biopharma industry has experienced a resurgence the first part of 2024. J.P. Morgan’s Q2 report shares critical insights into the future of the industry.
A recent U.S. complaint highlights the growing need for health care systems to ensure physician compensation aligns with fair market value to avoid compliance risks.
Ardent Health’s recent IPO highlights the company’s unique qualities, though it creates valuation comparability challenges for joint ventures and leased facilities.
The instances of urgent care clinic visits have returned to pre-pandemic levels, but COVID-related services still make up a large percentage of the total volume.
As Local Law 97 mandates emission reductions for large buildings in NYC, property owners are taking proactive steps to ensure compliance and avoid fines.
California issued new financial statement requirements that are effective as of January of last year for skilled nursing facilities (SNF).
Managing revenue cycles is an important aspect of modern hospital operations. Defined business processes and strong internal controls are the keys to optimization.
Featured in American Health Law Association’s online publication, Weaver partners Corey Palasota and Tashiana Briggs outline personal goodwill in health care M&A transactions.
1 2 3 4 19